Vendor, Sugar Land, TX, part of Quva Pharma Inc.
Quva Pharma, Inc.
UEI MUABDCZXMLG4, CAGE 7VLA4
9 awards and $220,893 obligated between April 17, 2024 and May 29, 2026, 0% under full and open competition, against 1.4 offers on average where reported. 1 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
| National Institutes of Health | $423,682 |
| Department of the Army | -$202,789 |
Industries
NAICS on the awards, by dollars.
| Pharmaceutical Preparation ManufacturingNAICS 325412 | $220,893 |
How it wins
Awards by competition, set-aside and type.
| Competed Under SAP | 6 |
| Not Competed Under SAP | 3 |
| Small Business Set Aside - Total | 1 |
| Purchase Order | 4 |
| Delivery Order | 3 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Notice of Intent to Sole Source; Monument Medical
National Institutes of Health, National Institutes of Health - CC
Special noticeSmall businessNAICS 339112Bethesda, MD25-000116Awarded to Quva Pharma, Inc.
Posted Oct 25, 2024
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N90024F00001Delivery Order, April 22, 2024, Competed Under SAP, 2 offers | National Institutes of Health - CCNational Institutes of Health | Outsourcing Pcas and EpiduralsNAICS 325412, PSC 6515 | $250,000 |
| 75N98026P00592Purchase Order, May 26, 2026, Competed Under SAP, 1 offers | National Institutes of Health OlaoNational Institutes of Health | Outsourcing Pcas and Epidurals for Patients Care from Quva Pharma, INC.NAICS 325412, PSC 6505 | $110,000 |
| 75N90025P00194Purchase Order, February 19, 2025, Not Competed Under SAP, 1 offers | National Institutes of Health - CCNational Institutes of Health | Pharmaceuticals Quva Pharma, INC.:1327585 [25-000116]NAICS 325412, PSC 6505 | $100,000 |
| 75N90025P00053Purchase Order, November 1, 2024, Not Competed Under SAP, 1 offers | National Institutes of Health - CCNational Institutes of Health | IV Medications Quva Pharma, INC.:1327585 [25-000665]NAICS 325412, PSC 6505 | $25,000 |
| 75N90019D00030April 17, 2024, Competed Under SAP, 2 offers | National Institutes of Health - CCNational Institutes of Health | Sterile Compounding 503B Facility Quva Pharma, INC.:1327585NAICS 325412, PSC 6515 | $0 |
| 75N90025D00001December 3, 2024, Not Competed Under SAP, 1 offersSolicitation | National Institutes of Health - CCNational Institutes of Health | Non Patient-Specific Sterile Compounded Pharmaceutical Products for Patients in the NIH CC on an as Called in Basis.NAICS 325412, PSC 6505 | $0 |
| 75N90019F00043Delivery Order, November 4, 2024, Competed Under SAP, 2 offers | National Institutes of Health - CCNational Institutes of Health | Quva Pharma, INC.:1327585 [19-017387]NAICS 325412, PSC 6515 | -$6,988 |
| 75N90020F00001Delivery Order, April 30, 2026, Competed Under SAP, 2 offers | National Institutes of Health - CCNational Institutes of Health | To Administratively De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in PreparatiNAICS 325412, PSC 6515 | -$54,330 |
| W81K0019P0334Purchase Order, April 21, 2025, Competed Under SAP, 1 offers | W40M MRC0 WestDepartment of the Army | Pharmaceuticals to Include Succinylcholine 20mg/MlNAICS 325412, PSC 6505 | -$202,789 |
- Product and service codes
- 6515 Medical and Surgical Instruments, Equipment, and Supplies6505 Drugs and Biologicals
- Transactions
- 12 across 9 awards